Brands: Ativan · Lorazepam
Average across 50 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Aphena Pharma Solutions - Tennessee, LLC | repackager | 165 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 54 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 29 | SUPPLYING |
| Proficient Rx LP | repackager | 25 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 23 | SUPPLYING |
| Asclemed USA, Inc. | repackager | 22 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | repackager | 21 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | repackager | 20 | SUPPLYING |
| Aurolife Pharma, LLC | unknown | 12 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 12 | SUPPLYING |
| Rising Pharma Holdings, Inc. | generic | 9 | SUPPLYING |
| Leading Pharma, LLC | unknown | 9 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | generic | 9 | SUPPLYING |
| ANI Pharmaceuticals, Inc. | generic | 9 | SUPPLYING |
| A-S Medication Solutions | repackager | 8 | SUPPLYING |
+ 13 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities. — Recalling firm: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — Nationwide U.S. and Puerto rico
Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities. — Recalling firm: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — Nationwide U.S. and Puerto rico
Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities. — Recalling firm: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — Nationwide U.S. and Puerto rico
Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam — Recalling firm: Leading Pharma, LLC — Nationwide in the USA
Labeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009 — Recalling firm: Legacy Pharmaceutical Packaging LLC — Distribution was made to IN.
